Skip to search formSkip to main contentSkip to account menu

Tigason

Known as: Tigazon 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Etretinate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
Highly Cited
1988
Highly Cited
1988
Derivation of retinoic acid and metabolites from a teratogenic dose of retinol (vitamin A) in mice.
1988
1988
Skeletal hyperostosis and extraosseous calcification in patients receiving long‐term etretinate (Tigason)
In an ongoing study of patients on long‐term etretinate (Tigason) therapy, 13 patients with a congenital or inherited disorder of… 
1986
1986
Inefficacy of the synthetic aromatic retinoid etretinate and of its free acid on the in-vitro differentiation of leukemic cells.
1984
1984
A serious side‐effect of etretinate (Tigason®)
A 19‐year‐old patient with lamellar ichthyosis is described. She received etretinate during 5 consecutive years. A serious… 
1983
1983
Treatment of extensive virus warts with etretinate (Tigason) in a patient with sarcoidosis
A case of extensive warts complicating sarcoidosis is reported. An excellent clinical response has been achieved by the use of… 
1983
1983
A randomized trial of etretinate (Tigason) in palmoplantar pustulosis.
5 patients with palmoplantar pustulosis (PPP) were randomized to 8 weeks of daily treatment with either oral etretinate, 1 mg/kg… 
1981
1981
The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease
Eighteen patients with Darier's disease were treated for at least 3 months with the oral aromatic retinoid Tigason (etretinate… 
1981
1981
Treatment of psoriasis by oral PUVA therapy combined with aromatic retinoid (Ro 10-9359; Tigason).
The authors discuss results observed in 126 patients affected with severe psoriasis covering more than 40% of the whole body area… 
1980
1980
Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double‐blind trial
In a multicentre double‐blind trial the effect of three therapy regimens was studied for 6 weeks in ninety psoriasis patients: 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)